GDNF Antibodies

Santa Cruz Biotechnology features a diverse variety of GDNF monoclonal antibodies for various research applications. GDNF Antibodies specific to glial cell line-derived neurotrophic factor (GDNF) enable precise detection through western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GDNF plays a crucial role in the survival and maintenance of neurons, particularly in the central and peripheral nervous systems. Ongoing research has demonstrated GDNF's essential function in the development of dopaminergic neurons. GDNF has been implicated in neurodegenerative diseases, making it a significant focus of research in neurobiology and therapeutic development. Understanding GDNF's function and mechanisms can provide insights into potential treatments for conditions such as Parkinson's disease. Investigating GDNF expression patterns and interactions helps reveal its role in neural development and regeneration. Current studies continue to uncover new aspects of GDNF's involvement in neuroprotection and repair. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing neuroscience discoveries and developing innovative therapeutic strategies.